ArticleBioengineering (Basel, Switzerland)2026
An Automated Modular Platform for Vascular Graft Assessment via Coronary-like Flow-Induced Stimulation.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Tissue-engineered vascular grafts (TEVGs) represent a promising alternative for coronary artery bypass grafting (CABG). However, replicating the mechanical and biological complexity of native vessels remains a major challenge. Compliance mismatch, local hemodynamics, and insufficient endothelialization are recognized as key contributors to maladaptive remodeling and graft failure. These limitations highlight the urgent need for advanced experimental platforms and standardized physical stimulation procedures to investigate these underlying biomechanisms and support the development of more effective TEVGs. In this work, we present an automated, modular platform designed to quantitatively characterize graft compliance and replicate coronary hemodynamics. The system integrates automated experimental procedures within a modular, incubator-compatible design, enabling an intuitive setup and real-time monitoring of physical parameters. Its modular architecture and dedicated control algorithms provide high adaptability, enabling its application across a broad range of experimental conditions. Bench testing demonstrates that the platform can automatically reproduce the pressure regimes defined by ISO standard and generate coronary-like flow-induced stimuli. These results confirm the innovative capability of the system to provide controlled and physiologically relevant conditions suitable for the investigation of key phenomena involved in CABG failure. In perspective, the platform offers a valuable tool for advanced mechanobiological studies in vascular tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.